Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 Receptor
Clinical trial NCT00923390 · TERMINATED
Trial details
- NCT number
- NCT00923390
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-02
- Primary completion
- 2012-08-24
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.